News from us and our partners

Tags

Topics

0 results

News
10 January, 2023
AFYREN adds new hires to support growth in France and expansion abroad
News
9 January, 2023
CinCor Pharma to be acquired by AstraZeneca
News
8 January, 2023
Sofinnova Partners Chair sees opportunity on the horizon
News
6 January, 2023
Amolyt Pharma announces $138 million Series C financing led by Sofinnova Partners and co-led by Intermediate Capital Group
News
5 January, 2023
Sofinnova Partners welcomes Mano Iyer as Venture Partner
News
5 January, 2023
Inspirna announces interim data from Phase 1b/2 study of Abequolixron (RGX-104) in relapsed or refractory lung cancer
News
3 January, 2023
MaxCyte signs strategic platform license with Catamaran Bio to support its CAR-NK cell therapy programs
News
22 December, 2022
Lilly and ProQR to expand RNA editing collaboration
News
20 December, 2022
Elicit Plant awarded up to €7.5 M funding from the European Commission through the EIC Accelerator program for deep tech start-ups
News
20 December, 2022
May Health completes treatment of five participants in U.S. feasibility study of its Ovarian Rebalancing treatment for PCOS-related infertility
News
20 December, 2022
AAVantgarde Founder and Chief Scientific Officer, Professor Alberto Auricchio, is elected as Vice President of the European Society of Gene and Cell Therapy
News
19 December, 2022
First U.S. patient successfully treated with Pi-Cardia’s ShortCut(TM)
News
19 December, 2022
EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology
News
19 December, 2022
F2G announces FDA filing acceptance of New Drug Application for olorofim for the treatment of invasive fungal Infections
News
15 December, 2022
Pixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024
News
13 December, 2022
Moon Surgical completes first-in-human clinical study with its Maestro™ Surgical Robotics System

AFYREN adds new hires to support growth in France and expansion abroad

CinCor Pharma to be acquired by AstraZeneca

Sofinnova Partners Chair sees opportunity on the horizon

Amolyt Pharma announces $138 million Series C financing led by Sofinnova Partners and co-led by Intermediate Capital Group

Sofinnova Partners welcomes Mano Iyer as Venture Partner

Inspirna announces interim data from Phase 1b/2 study of Abequolixron (RGX-104) in relapsed or refractory lung cancer

MaxCyte signs strategic platform license with Catamaran Bio to support its CAR-NK cell therapy programs

Lilly and ProQR to expand RNA editing collaboration

Elicit Plant awarded up to €7.5 M funding from the European Commission through the EIC Accelerator program for deep tech start-ups

May Health completes treatment of five participants in U.S. feasibility study of its Ovarian Rebalancing treatment for PCOS-related infertility

AAVantgarde Founder and Chief Scientific Officer, Professor Alberto Auricchio, is elected as Vice President of the European Society of Gene and Cell Therapy

First U.S. patient successfully treated with Pi-Cardia’s ShortCut(TM)

EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology

F2G announces FDA filing acceptance of New Drug Application for olorofim for the treatment of invasive fungal Infections

Pixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024

Moon Surgical completes first-in-human clinical study with its Maestro™ Surgical Robotics System